Description of 3 Cases in Vietnam of Aspirin Desensitization in Patients With Coronary Artery Disease and Coexisting Aspirin Hypersensitivity

Aspirin (ASA) hypersensitivity comprises types I to III (Cox-1 mediated) and types IV and V (IgE antibody mediated). Rapid, low-dose (81-325 mg/day) ASA desensitization regimens are known to be useful in establishing ASA tolerance in patients with coronary artery disease and coexisting ASA/nonsteroi...

Full description

Bibliographic Details
Main Authors: Dinh Van Nguyen, MD, Hieu Chu Chi, MD, Doan Van Nguyen, MD, PhD, Timothy J. Craig, DO, Sheryl van Nunen, MB, BS, MM, FRACP
Format: Article
Language:English
Published: Elsevier 2012-01-01
Series:World Allergy Organization Journal
Online Access:http://www.sciencedirect.com/science/article/pii/S1939455119303977

Similar Items